The effect of recombinant plasmids on in vivo colonisation of Salmonella enterica serovar Typhimurium strains is not reflected by in vitro cellular invasion assays

Vaccine

Volumn 20, Issue 27-28, 2002, Pages 3239-3243

  Garmory, Helen S ^a   Griffin, Kate F ^a   Leary, Sophie E C ^a   Perkins, Stuart D ^a   Brown, Katherine A ^b   Titball, Richard W ^a,c  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Invasion; Plasmid; Salmonella enterica serovar Typhimurium

Indexed keywords

DNA VACCINE; DRUG CARRIER; SALMONELLOSIS VACCINE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CELL INVASION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT PLASMID; RODENT; SALMONELLA ENTERICA; SEROTYPE;

ANIMALS; ANTIGENS; BACTERIAL VACCINES; CELL LINE; FEMALE; MICE; MICE, INBRED BALB C; PLASMIDS; RECOMBINATION, GENETIC; SALMONELLA TYPHIMURIUM; TYPHOID-PARATYPHOID VACCINES; VACCINES, ATTENUATED; VACCINES, DNA;

EID: 0037056015     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00292-X     Document Type: Article

References (22)

1. Levine M.M., Galen J., Barry E.et al. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors. J. Biotechnol. 44:1996;193-196.
2. Chatfield SN, Dougan G, Roberts M. Progress in the development of multivalent oral vaccines based on live attenuated Salmonella. In: Kurstak E, editor. Modern Vaccinology. New York: Plenum Medical Book Company, 1994. p. 55-86.
3. Hormaeche C.E. Live attenuated salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens. J. Immunol. Methods. 142:1991;113-120.
4. Darji A., zur Lage S., Garbe A.I., Chakraborty T., Weiss S. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol. Med. Microbiol. 27:1999;341-349.
5. Stocker B.A.D. Aromatic-dependant Salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them. J. Biotechnol. 83:2000;45-50.
6. Dietrich G., Goebel W. DNA vaccine delivery by attenuated intracellular bacteria. Subcell Biochem. 33:2000;541-557.
7. Finlay B.B., Brumell J.H. Salmonella interactions with host cells: in vitro to in vivo. Phil. Trans. R. Soc. Lond. B. 355:2000;623-631.
8. + for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156:1983;471-474.
9. Hosieth S.K., Stocker B.A.D. Aromatic-dependant Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 291:1981;238-239.
10. Khan C.M., Villareal-Ramos B., Pierce R.J.et al. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live aro attenuated vaccine strain of Salmonella. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11261-11265.
11. Amann E., Ochs B., Abel K.J. Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene. 69:1988;301-315.
12. MacGregor G.R., Caskey C.T. Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucleic Acids Res. 17:1989;2365.
13. Coulson N.M., Fulop M., Titball R.W. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium, affords protection against anthrax spore challenge. Vaccine. 12:1994;1395-1401.
14. Hone DM, Shata MT, Pascual DW, Lewis GK. Mucosal vaccination with Salmonella vaccine vectors. In: Paterson Y, editor. Intracellular Bacterial Vaccine Vectors. New York: Wiley, 1999. p. 171-222.
15. Coulson N.M., Fulop M., Titball R.W. Effect of different plasmids on colonization of mouse tissues by the aromatic amino acid dependant Salmonella typhimurium SL3261. Microb. Pathog. 16:1995;305-311.
16. Darji A., Guzmán C.A., Gerstel B.et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell. 91:1997;765-775.
17. Jones B.D., Ghori N., Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialised epithelial M-cells of the Peyer's patches. J. Exp. Med. 180:1994;15-23.
18. Worton K.J., Candy D.C.A., Wallis T.S.et al. Studies on early association of Salmonella typhimurium with intestinal mucosa in vivo and in vitro: relationship to virulence. J. Med. Microbiol. 29:1989;283-294.
19. Watson P.R., Paulin S.M., Jones P.W., Wallis T.S. Interaction of Salmonella serotypes with porcine macrophages in vitro does not correlate with virulence. Microbiology. 146:2000;1639-1649.
20. Kok M., Bühlmann E., Pechère J.-C. Salmonella typhimurium thyA mutants fail to grow intracellularly in vitro and are attenuated in mice. Microbiology. 147:2001;727-733.
21. Clark M.A., Reed K.A., Lodge J., Stephen J., Hirst B.H., Jepson M.A. Invasion of murine intestinal M-cells by Salmonella typhimurium inv mutants severely deficient for invasion of cultured cells. Infect. Immunol. 64:1996;4363-4368.
22. Woo P.C.Y., Wong L., Zheng B., Yuen K. Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium. Vaccine. 19:2001;2945-2954.